These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13741365)

  • 21. Synthesis and biological evaluation of C-3 aliphatic coumarins as vitamin K antagonists.
    Montagut-Romans A; Boulven M; Jacolot M; Moebs-Sanchez S; Hascoët C; Hammed A; Besse S; Lemaire M; Benoit E; Lattard V; Popowycz F
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1598-1601. PubMed ID: 28254487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mode of antagonism of vitamin K by anticoagulants.
    Nutr Rev; 1978 Sep; 36(9):289-91. PubMed ID: 714310
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent developments in understanding the mechanism of vitamin K and vitamin K-antagonist drug action and the consequences of vitamin K action in blood coagulation.
    Jackson CM; Suttie JW
    Prog Hematol; 1977; 10():333-59. PubMed ID: 337364
    [No Abstract]   [Full Text] [Related]  

  • 24. [Metabolism of vitamin K antagonists].
    Blatrix C; Tillement JP
    Therapeutique; 1969 Nov; 45(9):875-7. PubMed ID: 5365412
    [No Abstract]   [Full Text] [Related]  

  • 25. [New insight in therapeutic anticoagulation by Coumarin derivatives].
    Oldenburg J; Seidel H; Pötzsch B; Watzka M
    Hamostaseologie; 2008 Feb; 28(1-2):44-50. PubMed ID: 18278162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

  • 27. [Resistance to coumarin derivatives due to mutated vitamin-K enzyme].
    Hermans MH; Poodt J; van Geest-Daalderop JH; Péquériaux NC; Conemans JM
    Ned Tijdschr Geneeskd; 2009; 153():A691. PubMed ID: 19857286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vitamin K antagonists contraindicated in chronic kidney disease].
    Engels T
    Internist (Berl); 2017 Sep; 58(9):1005. PubMed ID: 28795199
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply: Is a Trial of Vitamin K Antagonists and Bisphosphonates Possible in IPF?
    Margaritopoulos GA; Antoniou KM
    Am J Respir Crit Care Med; 2017 Jan; 195(2):271-272. PubMed ID: 28084829
    [No Abstract]   [Full Text] [Related]  

  • 30. The genetics of vitamin K antagonists.
    Gage BF; Eby CS
    Pharmacogenomics J; 2004; 4(4):224-5. PubMed ID: 15148502
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vitamin K antagonists in severe kidney disease associated with regulatory problems].
    Uhlemann H
    Internist (Berl); 2017 Sep; 58(9):1004. PubMed ID: 28795200
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current anticogulants].
    BERGOGNE C
    Sem Hop Ther Paris; 1962 Jun; 38():549-51. PubMed ID: 13867779
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants.
    Pearson DA
    Nutr Clin Pract; 2007 Oct; 22(5):517-44. PubMed ID: 17906277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanisms.
    Self TH; Oliphant CS; Reaves AB; Richardson AM; Sands CW
    Thromb Res; 2015 Jan; 135(1):5-8. PubMed ID: 25456000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vitamin K: biochemistry, function, and deficiency. Review].
    Mijares ME; Nagy E; Guerrero B; Arocha-Piñango CL
    Invest Clin; 1998 Sep; 39(3):213-29. PubMed ID: 9780555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Conditions of resistance to vitamin K antagonists].
    Marchal G; Samama M; Charon P
    Sem Ther; 1964 Dec; 40(10):623-7. PubMed ID: 5878936
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antagonistic effect of thrombosan and vitamin K on blood coagulation].
    ZALOGA K; DOWGIALLO Z
    Pol Tyg Lek (Wars); 1956 Mar; 11(11):481-3. PubMed ID: 13349668
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mechanism of action of coumarin anti-coagulants (author's transl)].
    Martius F
    Ther Umsch; 1977 May; 34(5):329-33. PubMed ID: 867312
    [No Abstract]   [Full Text] [Related]  

  • 40. Coumarin drug interactions.
    Kazmier FJ; Spittell JA
    Mayo Clin Proc; 1970 Apr; 45(4):249-55. PubMed ID: 5439135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.